Navigating AlphaMark's Q3 and Q4 2022 13F Holdings: A Data Analysis
Ava Hoppe | 2 May, 2023
---
Recently, AlphaMark Advisors, LLC released its Q3 and Q4 2022 13F holdings data - revealing the firm's latest holding changes in 34 selected issuers. From stocks and exchange-traded funds to options, AlphaMark's latest activity indicates the firm's investment strategy outlook amidst emerging market trends. In this article, we'll analyze the data and provide insights on the firm's focus for the upcoming year.
First, let's take a closer look at AlphaMark's major holdings. According to the data, AlphaMark's top holdings, based on the highest percentage change, are:
- Ultat Beauty Inc: +2570.8%
- Waste Management Inc: -7%
- Amazon Com Inc: -26.9%
The firm's top percentage-change holdings reveal a strategy focused on emerging trends and growth sectors that are likely to continue outperforming the market. Ulta Beauty Inc's significant increase signals AlphaMark's trust in the cosmetic industry to keep growing. Waste Management Inc's decrease may reflect a more conservative investor outlook, choosing to be less exposed to the industry's volatility. Amazon Com Inc's decrease, on the other hand, may mean that the firm is churning to reinvest gains.
Now, let's analyze AlphaMark's sectors and industries. Based on the data, their highest sector allocation is Information Technology (24.1%), followed by Health Care (17.7%). AlphaMark's most significant holdings within their top sectors are:
- Technology SPDR: -5.7% (percentage change)
- Health Care SPDR: +17.7% (percentage change)
Technology and Health Care are currently the most significant sectors for AlphaMark, with Technology taking first place for the quarter. Though Technology SPDR saw a decrease in holdings, this sector is typically known for continuous innovation and growth potential, so a decrease in holdings shouldn't be a surprise. Health Care is also a steady performer, and its increase in holdings may be an indication of the firm's bullish outlook on the sector.
Apart from these sectors, AlphaMark also has a significant holding in Consumer Staples (9.4%), which includes brands such as Procter & Gamble, Kroger, and Lowe's Companies. Besides, there are also holdings in Financials (8.4%), with Fifth Third Bancorp being among the top five holdings in this sector.
Lastly, we can analyze AlphaMark's sub-industries. Based on the data, their highest sub-industry allocation is Pharmaceuticals, Biotechnology & Life Sciences (13.0%), followed by Software, Services (9.0%), and Food and Staples Retailing (9.0%). AlphaMark's most significant holdings within their top sub-industries are:
- Vertex Pharmaceuticals: -3.7% (percentage change)
- Edwards Lifesciences: +0% (percentage change)
- Ross Stores: +46.2% (percentage change)
AlphaMark Advisors' holdings in Pharmaceuticals, Biotechnology & Life Sciences is yet another indication of a focus on innovation, as this sub-industry is critical to producing and distributing new medicines and treatments. Verdict Pharmaceuticals saw a decrease in holdings, while Edwards Lifesciences remained constant. Meanwhile, AlphaMark's holding in Ross Stores saw the most significant percentage increase within the top three sub-industries, signaling the firm's potential trust in the consumer retail industry.
In conclusion, AlphaMark Advisors LLC's Q3-Q4 2022 13F Holdings reveal a mixed strategy from the firm, with an inclination towards growth areas such as technology, pharmaceuticals, and cosmetics. The firm's holdings also show a fairly diverse allocation with holdings in various sectors and sub-industries. Although AlphaMark's allocations and changes to them require continued monitoring, investors can take cues from these holdings and offer some insight into potential investment strategies for the coming year.
Other Posts
- Antin Infrastructure Partners: Investing in the Future with Share Issuance
- The Future of Financial Services Advisory: A Look at Q4 2022 vs. Q1 2023 Holdings
- Analyzing Shepherd Kaplan Krochuk's Q4 2022 13F Filings: Changes in Holdings and Investment Strategy Insights
- UBS Asset Management's Q3-Q4 2022 Holdings Comparison: Tech Falters, Healthcare Surges
- Investment Strategies Revealed: Navigating the Shifts in Q4 2023 to Q1 2024 Fund Holdings
- GenWealth Group, Inc. Q1 2023 vs. Q2 2023 13F Holdings: Analysis and Insights
- Harrington Process Solutions Acquired by Bain Capital Private Equity: A New Era of Growth and Innovation in Flow Control Process Solutions
- Exploring the Winds of Change: How Aspiriant, LLC Adjusted Its Portfolio in Early 2024
- Navigating Market Shifts: How Ellenbecker Investment Group Adjusts its Sails in Q1 2024
- Acuitas Investments, LLC Q4 2022 vs. Q1 2023 - Top Gainers and Losers